Enteral Lactoferrin Mitigates Myocardial ischemia-reperfusion Injury Via Enteral Lactoferrin-induced glucagon-like peptide-1 in Isolated Rat Heart Model
Authors:
- 30 August 2025
- journal article
- research article
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 31 (5) , 1-7
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (21K08965)
This publication has 14 references indexed in Scilit:
- Role of the protein kinase A signaling pathway and identification of mediators in the cardioprotective effects of enteral lactoferrin for ischemia-reperfusion injury in an isolated rat heart modelNutrition, 2023
- Glucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioningCardiovascular Research, 2016
- GLP-1 and cardioprotection: from bench to bedsideCardiovascular Research, 2012
- Effects of pepsin and trypsin on the anti-adipogenic action of lactoferrin against pre-adipocytes derived from rat mesenteric fatBritish Journal of Nutrition, 2010
- Lactoferrin: structure, function and applicationsInternational Journal of Antimicrobial Agents, 2009
- 28-Day repeated dose oral toxicity of recombinant human holo-lactoferrin in ratsRegulatory Toxicology and Pharmacology, 2008
- Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent PathwaysCirculation, 2008
- Protection against infections by oral lactoferrin: Evaluation in animal modelsBioMetals, 2004
- Evidence of lactoferrin transportation into blood circulation from intestine via lymphatic pathway in adult ratsExperimental Physiology, 2004
- Antiviral activities of lactoferrinAntiviral Research, 2001